[HTML][HTML] Treatment of giardiasis after nonresponse to nitroimidazole
E Meltzer, T Lachish, E Schwartz - Emerging infectious diseases, 2014 - ncbi.nlm.nih.gov
E Meltzer, T Lachish, E Schwartz
Emerging infectious diseases, 2014•ncbi.nlm.nih.govAbstract During January 2008–October 2013, a total of 12 cases of giardiasis at the Chaim
Sheba and Shaare Zedek Medical Centers, Israel, did not respond to nitroimidazole; 83.3%
were associated with travel and 33% with immunoglobulin deficiency. Among 110 published
cases, the most effective treatment was quinacrine (efficacy 90%–100%), but its availability
is limited.
Sheba and Shaare Zedek Medical Centers, Israel, did not respond to nitroimidazole; 83.3%
were associated with travel and 33% with immunoglobulin deficiency. Among 110 published
cases, the most effective treatment was quinacrine (efficacy 90%–100%), but its availability
is limited.
Abstract
During January 2008–October 2013, a total of 12 cases of giardiasis at the Chaim Sheba and Shaare Zedek Medical Centers, Israel, did not respond to nitroimidazole; 83.3% were associated with travel and 33% with immunoglobulin deficiency. Among 110 published cases, the most effective treatment was quinacrine (efficacy 90%–100%), but its availability is limited.
ncbi.nlm.nih.gov
以上显示的是最相近的搜索结果。 查看全部搜索结果